Abstract | OBJECTIVE: METHODS: One hundred and twenty patients were randomly divided into 6 groups. Another 10 patients as the control group were confirmed with no peptic ulcers by endoscope, but had digestive tract symptoms. The clinical effects were compared among each group after the one month treatment. RESULTS: The clinical effects of the combination of Jianweiyuyang granules and ranitidine capsules were better than those of western medicine, with improvement in symptoms and syndrome (P < 0.01 to 0.05), but there was not significant difference with the rate of ulcer healing and the Hp clearance among the combination of Jianweiyuyang granules and ranitidine capsules, Jianweiyuyang granules, and ranitidine capsules (P > 0.05). The combination of Jianweiyuyang granules and ranitidine capsules could significantly upregulate the expression of MUCSAC mRNA (P < 0.01), while downregulate the expression of ETAR mRNA (P < 0.01). CONCLUSION: There is obvious advantage in treating peptic ulcers by the combination of Jianweiyuyang granules and ranitidine capsules, and its mechanisms may be to protect the gastric mucosal barrier by up-regulating the expression of MUCSAC mRNA and to improve the gastric mucosal blood flow by down-regulating the expression of ETAR mRNA.
|
Authors | Bing Zhou, Jia-bang Li, Guang-xian Cai, Jiang-hong Ling, Xing-ping Dai |
Journal | Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
(Zhong Nan Da Xue Xue Bao Yi Xue Ban)
Vol. 30
Issue 6
Pg. 714-8
(Dec 2005)
ISSN: 1672-7347 [Print] China |
PMID | 16708818
(Publication Type: English Abstract, Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Capsules
- Drugs, Chinese Herbal
- Endothelin-1
- MUC5AC protein, human
- Mucin 5AC
- Mucins
- RNA, Messenger
- Receptors, Endothelin
- Ranitidine
|
Topics |
- Adult
- Capsules
- Drug Therapy, Combination
- Drugs, Chinese Herbal
(therapeutic use)
- Endothelin-1
(biosynthesis, genetics)
- Female
- Gastric Mucosa
(metabolism)
- Humans
- Male
- Middle Aged
- Mucin 5AC
- Mucins
(biosynthesis, genetics)
- Peptic Ulcer
(drug therapy)
- Phytotherapy
- RNA, Messenger
(biosynthesis, genetics)
- Ranitidine
(therapeutic use)
- Receptors, Endothelin
(biosynthesis, genetics)
|